Granted Patent B2

US 12,383,203 · App. 18/350,444 · Granted Aug 12, 2025

Inventors: Saul E. Greenhut (Denver, CO); Yuanzhen Liu (Palo Alto, CA); Xusheng Zhang (Shoreview, MN)

Assignee: Medtronic, Inc.

A61B5/7203A61B5/33A61B5/346A61B5/363A61B5/4836A61B5/7221A61N1/365

Abstract

Claims (110)

1. A medical device comprising:

a sensing circuit configured to:

sense one or more cardiac electrical signals; and

sense event signals from the one or more cardiac electrical signals;

a therapy delivery circuit configured to deliver a tachyarrhythmia therapy;

a control circuit coupled to the sensing circuit and the therapy delivery circuit, the control circuit configured to:

for each of a plurality of event signals sensed by the sensing circuit, determine a peak amplitude from one of the one or more cardiac electrical signals;

determine a lowest peak amplitude from the determined peak amplitudes;

determine a greatest peak amplitude from the determined peak amplitudes;

determine at least one suspected true cardiac event interval from the peak amplitudes;

determine that the at least one suspected true cardiac event interval is outside a true tachyarrhythmia evidence interval range;

in response to the at least one suspected true cardiac event interval being outside the true tachyarrhythmia evidence interval range, apply suspected noise criteria to the determined peak amplitudes for detecting noise corruption;

determine that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria;

detect noise corruption of the one or more cardiac electrical signals based on at least the lowest peak amplitude and the greatest peak amplitude determined for the plurality of event signals meeting the suspected noise criteria; and

control the therapy delivery circuit to withhold the tachyarrhythmia therapy in response to detecting the noise corruption.

2. The medical device of claim 1 wherein the control circuit is further configured to determine the lowest peak amplitude by:

identifying at least two smallest peak amplitude values of the determined peak amplitudes; and

determining the lowest peak amplitude based on at least the two smallest peak amplitude values.

3. The medical device of claim 1 wherein the control circuit is further configured to determine that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria by:

determining a ratio of the greatest peak amplitude to the lowest peak amplitude; and

determining that the ratio is greater than a ratio threshold.

4. The medical device of claim 1 wherein the control circuit is further configured to determine that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria by determining that the lowest peak amplitude is less than a noise amplitude threshold.

5. The medical device of claim 4 wherein the control circuit is further configured to:

determine one or more R-wave peak amplitudes from the one or more cardiac electrical signals; and

determine the noise amplitude threshold from the one or more R-wave peak amplitudes.

6. The medical device of claim 1 wherein:

the sensing circuit is further configured to:

sense the one or more cardiac electrical signals by sensing at least a first cardiac electrical signal and a second cardiac electrical signal; and

sense the event signals from a first cardiac electrical signal; and

the control circuit is further configured to determine the peak amplitude for each of the plurality of event signals sensed by the sensing circuit by determining a peak to peak amplitude from the second cardiac electrical signal.

7. The medical device of claim 1 wherein the control circuit is further configured to:

determine at least one tachyarrhythmia metric based on at least the identified greatest maximum amplitude;

determine the at least one tachyarrhythmia metric does not meet true tachyarrhythmia evidence criteria; and

determine that the suspected noise criteria are met when the at least one tachyarrhythmia metric does not meet the true tachyarrhythmia evidence criteria.

8. The medical device of claim 1 wherein the control circuit is further configured to:

identify at least two smallest peak amplitude values of the determined peak amplitudes;

determine the lowest peak amplitude based on at least the two smallest peak amplitude values;

determine a ratio of the greatest peak amplitude to the lowest peak amplitude; and

determine that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria by at least:

determining that the ratio is greater than a ratio threshold; and

determining that the lowest peak amplitude is less than a noise threshold.

9. The medical device of claim 1 wherein the control circuit is further configured to:

detect a threshold number of tachyarrhythmia intervals based on the event signals sensed by the sensing circuit;

in response to detecting noise corruption, withhold a tachyarrhythmia detection based on the threshold number of tachyarrhythmia intervals being detected; and

control the therapy delivery circuit to withhold the tachyarrhythmia therapy by withholding the tachyarrhythmia detection.

10. The medical device of claim 9 wherein:

the control circuit is further configured to:

determine that the suspected noise criteria are not met based on a second plurality of cardiac events sensed by the sensing circuit;

determine that noise corruption is not detected based on at least the second plurality of cardiac events sensed by the sensing circuit not meeting the suspected noise criteria; and

detect a tachyarrhythmia in response to the threshold number of tachyarrhythmia intervals being detected and noise corruption not being detected; and

the therapy delivery circuit further configured to deliver the tachyarrhythmia therapy in response to the tachyarrhythmia detection.

11. The medical device of claim 1 wherein the control circuit is further configured to determine that the at least one suspected true cardiac event interval is outside the true tachyarrhythmia evidence interval range by determining that the at least one suspected true cardiac event interval is less than a lower limit of the true tachyarrhythmia evidence interval range.

12. A method comprising:

sensing one or more cardiac electrical signals;

sensing event signals from the one or more cardiac electrical signals;

for each of a plurality of sensed event signals, determining a peak amplitude from one of the one or more cardiac electrical signals;

determining a lowest peak amplitude from the determined peak amplitudes;

determining a greatest peak amplitude from the determined peak amplitudes;

determining at least one suspected true cardiac event interval from the peak amplitudes;

determining that the at least one suspected true cardiac event interval is outside a true tachyarrhythmia evidence interval range;

in response to the at least one suspected true cardiac event interval being outside the true tachyarrhythmia evidence interval range, applying suspected noise criteria to the determined peak amplitudes for detecting noise corruption;

determining that the lowest peak amplitude and the greatest peak amplitude meet suspected noise criteria;

detecting noise corruption of the one or more cardiac electrical signals based on at least the lowest peak amplitude and the greatest peak amplitude determined for the plurality of event signals meeting the suspected noise criteria; and

withholding a tachyarrhythmia therapy in response to detecting the noise corruption.

13. The method of claim 12 wherein determining the lowest peak amplitude comprises:

identifying at least two smallest peak amplitude values of the determined peak amplitudes; and

determining the lowest peak amplitude based on at least the two smallest peak amplitude values.

14. The method of claim 12 wherein determining that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria comprises:

determining a ratio of the greatest peak amplitude to the lowest peak amplitude; and

determining that the ratio is greater than a ratio threshold.

15. The method of claim 12 wherein determining that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria comprises determining that the lowest peak amplitude is less than a noise amplitude threshold.

16. The method of claim 15 further comprising:

determining one or more R-wave peak amplitudes from the one or more cardiac electrical signals; and

determining the noise amplitude threshold from the one or more R-wave peak amplitudes.

17. The method of claim 12 further comprising:

sensing the one or more cardiac electrical signals by sensing at least a first cardiac electrical signal and a second cardiac electrical signal;

sensing the event signals from the first cardiac electrical signal; and

determining the peak amplitude for each of the plurality of event signals by determining a peak to peak amplitude from the second cardiac electrical signal.

18. The method of claim 12 wherein determining that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria comprises:

determining at least one tachyarrhythmia metric based on at least the identified greatest maximum amplitude;

determining the at least one tachyarrhythmia metric does not meet true tachyarrhythmia evidence criteria; and

determining that the suspected noise criteria are met when the at least one tachyarrhythmia metric does not meet the true tachyarrhythmia evidence criteria.

19. The method of claim 12 further comprising:

identifying at least two smallest peak amplitude values of the determined peak amplitudes;

determining the lowest peak amplitude based on at least the two smallest peak amplitude values;

determining a ratio of the greatest peak amplitude to the lowest peak amplitude; and

determining that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria by at least:

determining that the ratio is greater than a ratio threshold; and

determining that the lowest peak amplitude is less than a noise threshold.

20. The method of claim 12 further comprising:

detecting a threshold number of tachyarrhythmia intervals based on the event signals sensed by the sensing circuit;

in response to detecting 0.noise corruption, withholding a tachyarrhythmia detection based on the threshold number of tachyarrhythmia intervals being detected; and

withholding the tachyarrhythmia therapy by withholding the tachyarrhythmia detection.

21. The method of claim 20 further comprising:

determining that the suspected noise criteria are not met based on a second plurality of cardiac events;

determining that noise corruption is not detected based on at least the second plurality of cardiac events not meeting the suspected noise criteria;

detecting a tachyarrhythmia in response to the threshold number of tachyarrhythmia intervals being detected and noise corruption not being detected; and

delivering the tachyarrhythmia therapy in response to the tachyarrhythmia detection.

22. A non-transitory computer readable medium storing a set of instructions which, when executed by a control circuit of a medical device, cause the medical device to:

sense one or more cardiac electrical signals;

sense event signals from the one or more cardiac electrical signals;

for each of a plurality of sensed event signals, determine a peak amplitude from one of the one or more cardiac electrical signals;

determine a lowest peak amplitude from the determined peak amplitudes;

determine a greatest peak amplitude from the determined peak amplitudes;

determine at least one suspected true cardiac event interval from the peak amplitudes;

determine that the at least one suspected true cardiac event interval is outside a true tachyarrhythmia evidence interval range;

in response to the at least one suspected true cardiac event interval being outside the true tachyarrhythmia evidence interval range, apply suspected noise criteria to the determined peak amplitudes for detecting noise corruption;

determine that the lowest peak amplitude and the greatest peak amplitude meet the suspected noise criteria;

detect noise corruption of the one or more cardiac electrical signals based on at least the lowest peak amplitude and the greatest peak amplitude determined for the plurality of event signals meeting the suspected noise criteria; and

withhold a tachyarrhythmia therapy in response to detecting the noise corruption.

Assignments (1)

Continuity (2)

References Cited (26)